by David Brindley | Oct 25, 2013
. Nestled in the bosom of the Canadian Rockies, the global regenerative medicine community is assembled. Coaches laden with young investigators sporting impractically packed posters and drawn, jet lagged expressions are arriving in a steady procession. The usually...
by David Brindley | Oct 24, 2013
. 9am, Day 1: IBC Cell Therapy Bioprocessing Conference (Bethesda, MD, USA): Attempting to sharpen tie, and my welcome isolation is interrupted by a lady entering the elevator and fighting for mirror space. Cue small talk: “That’s a nice tie.” “Erm, thank you.” “And...
by Lisa Willemse | Oct 21, 2013
> If the thought of majestic mountains, impossibly blue skies and natural hot springs isn’t enough to put Banff, Alberta into your calendar this week, then perhaps this preview of the Till & McCulloch Meetings will change your mind. This is the second...
by Mark Curtis | Oct 17, 2013
. Welcome to the first Regenerative Medicine Deal Review, an overview of recent licensing, partnering, and financing activity all exclusively in the regenerative medicine and cell therapy industries. Like my first post ‘Update from the Clinic’, this piece is intended...
by Stacey Johnson | Oct 4, 2013
. With over 1,000 TED Talks, it’s inevitable that more than one good regenerative medicine talk will appear in Right Turn. The talk below, by Dr. Robert Langer of MIT, takes some commitment at nearly 18 minutes in running time, but if you’re a fan of biomaterials (or...
by Mark Curtis | Oct 3, 2013
. I have recently joined the business development group at CCRM, as an analyst, and believe it would be useful to start compiling some recaps on clinical developments in the regenerative medicine (RM) and cell therapy industries to complement the other science-related...
Comments